Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
Young Il Kim, Ju Young Yoon, Jun Eul Hwang, Hyun Jeong Shim, Woo Kyun Bae, Sang Hee Cho, Ik-Joo Chung
Cancer Res Treat. 2010;42(4):244-246.   Published online 2010 Dec 31     DOI: https://doi.org/10.4143/crt.2010.42.4.244
Citations to this article as recorded by Crossref logo
Ifosfamide-induced nephrotoxicity in oncological patients
Juan Eduardo Quiroz-Aldave, María Del Carmen Durand-Vásquez, Freddy Shanner Chávez-Vásquez, Alexandra Noelia Rodríguez-Angulo, Sonia Elizabeth Gonzáles-Saldaña, Carlos César Alcalde-Loyola, Julia Cristina Coronado-Arroyo, Francisca Elena Zavaleta-Gutiérre
Expert Review of Anticancer Therapy.2024; 24(1-2): 5.     CrossRef
Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE
Ahmet Kursad Gunes, Simten Dagdas, Funda Ceran, Mehmet Ali Ucar, Mesude Falay, Cenk Sunu, Meltem Ayli, Nurullah Zengin, Gulsum Ozet
Indian Journal of Hematology and Blood Transfusion.2021; 37(1): 82.     CrossRef
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
S. D’Oronzo, S. Stucci, M. Tucci, F. Silvestris
Cancer Treatment Reviews.2015; 41(9): 798.     CrossRef
Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity
M. Airy, R. Raghavan, L. D. Truong, G. Eknoyan
Nephrology Dialysis Transplantation.2013; 28(10): 2502.     CrossRef